The issue of stroke and bleeding events following transcatheter aortic valve implantation (TAVI) and its relation with antithrombotic regimens before, during and after the procedure is increasingly recognized as an important issue. While dedicated trials are ongoing, there is no clear evidence at present on the best antithrombotic regimen in the context of TAVI. In this article, we will go through the mechanisms involved in embolic and bleeding complications of TAVI, and we will discuss the key aspects of antithrombotic treatment in patients undergoing TAVI.
Antithrombotic therapy following transcatheter aortic valve implantation: what challenges do we face?
TAMBURINO, Corrado;CAPODANNO, DAVIDE FRANCESCO MARIA
2016-01-01
Abstract
The issue of stroke and bleeding events following transcatheter aortic valve implantation (TAVI) and its relation with antithrombotic regimens before, during and after the procedure is increasingly recognized as an important issue. While dedicated trials are ongoing, there is no clear evidence at present on the best antithrombotic regimen in the context of TAVI. In this article, we will go through the mechanisms involved in embolic and bleeding complications of TAVI, and we will discuss the key aspects of antithrombotic treatment in patients undergoing TAVI.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Exp. Rev. Cardiovasc. Ther. 2016_Anti-thrombotic therapy following TAVI.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Dimensione
4.32 MB
Formato
Adobe PDF
|
4.32 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.